Your Treatment Protocol Following your consultation and confirmation of suitability, your treatment protocol will be tailored to your individual needs and the degree of deficiency identified
Provincial drug programs may impose step therapy requirements, meaning patients must trial less expensive alternatives before accessing newer agents
The injectable nature of GLP-1 RAs presents both challenges and opportunities for clinics: Challenges: Patient anxiety about self-injection, training requirements, cost of devices Opportunities: Regular contact with healthcare providers, controlled dispensing, ability to monitor adherence Administration Methods: Glutathione Unlike GLP-1 receptor agonists, glutathione can be administered through multiple routes, each with distinct advantages and considerations: 1
The first GLP-1 receptor agonist was approved for diabetes treatment in 2005
For immediate use, store the eluates at 2-8 C